Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Chinese astronauts’ return to Earth delayed over fears spaceship damaged by debris - 2From Exemplary to Current: Famous Rings Available
- 3British-Egyptian dissident apologises for tweets as Tories push for UK deportation
- 4Russian authorities threaten WhatsApp with total ban
- 5Amateur's Manual for Venture Strategies for Tenderfoots
- Father and son spending Christmas together after health scares
- A rare whale is having an encouraging season for births. Scientists warn it might still go extinct
- IDF destroys two-kilometer-long Gaza terror tunnel in Beit Lahiya
- 6 Methods for further developing Rest Quality
- Between 600 to 800 aid trucks entering Gaza daily since start of ceasefire, COGAT confirms
- Vote In favor of Your Favored IT Administration
- NASA will bring space station crew home early after medical issue
- Find Unexpected, yet invaluable treasure Excursion Rentals
- Like many holiday traditions, lighting candles and fireplaces is best done in moderation
